THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Penserra Capital Management LLC's Holding History (CIK: 0001593324)

Note: Option positions (PUT/CALL) are excluded.

Q3 2021

Shares 1,685 Value ($000) $12 Avg Close $11.19 Range $6.10 - $15.01

Q2 2021

Shares 1,485 Value ($000) $21 Avg Close $18.78 Range $14.46 - $22.74

Q1 2021

Shares 1,460 Value ($000) $29 Avg Close $19.01 Range $16.46 - $21.21

Q4 2020

Shares 1,465 Value ($000) $26 Avg Close $17.95 Range $14.48 - $20.53

Q3 2020

Shares 542 Value ($000) $8 Avg Close $18.73 Range $14.62 - $22.82

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2021	1,685	$12	$11.19	$6.10 - $15.01
Q2 2021	1,485	$21	$18.78	$14.46 - $22.74
Q1 2021	1,460	$29	$19.01	$16.46 - $21.21
Q4 2020	1,465	$26	$17.95	$14.48 - $20.53
Q3 2020	542	$8	$18.73	$14.62 - $22.82